MX2022002881A - Proceso para la produccion de 5-(4-((2s,5s)-5-(4-clorobencil)-2-me tilmorfolino)piperidin-1-il)-1h-1,2,4-triazol-3-amina. - Google Patents

Proceso para la produccion de 5-(4-((2s,5s)-5-(4-clorobencil)-2-me tilmorfolino)piperidin-1-il)-1h-1,2,4-triazol-3-amina.

Info

Publication number
MX2022002881A
MX2022002881A MX2022002881A MX2022002881A MX2022002881A MX 2022002881 A MX2022002881 A MX 2022002881A MX 2022002881 A MX2022002881 A MX 2022002881A MX 2022002881 A MX2022002881 A MX 2022002881A MX 2022002881 A MX2022002881 A MX 2022002881A
Authority
MX
Mexico
Prior art keywords
methylmorpholino
chlorobenzyl
triazol
piperidin
amine
Prior art date
Application number
MX2022002881A
Other languages
English (en)
Inventor
Grzegorz Witkowski
Marta Magdycz
Magdalena Tyszkiewicz
Marcin Zakrzewski
Stanislaw Pikul
Original Assignee
Oncoarendi Therapeutics Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncoarendi Therapeutics Sa filed Critical Oncoarendi Therapeutics Sa
Publication of MX2022002881A publication Critical patent/MX2022002881A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/68—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D211/72—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D211/74—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)

Abstract

La presente invención se relaciona con un proceso para la síntesis de la 5-(4-((2S,5S)-5-(4-clorobencil)-2-metilmorfolino)pi peridin-1-il)-1H-1,2,4-triazol-3-amina en dos formas cristalinas hidratadas y en una forma cristalina anhidra. La presente invención además se relaciona con el (Z)-4-((2S,5S)-5-(4-clorobenc il)-2-metilmorfolino)-N-ciano-piperidina-1-carbimidotioato de metilo que es el compuesto intermediario en este proceso.
MX2022002881A 2019-09-25 2020-09-25 Proceso para la produccion de 5-(4-((2s,5s)-5-(4-clorobencil)-2-me tilmorfolino)piperidin-1-il)-1h-1,2,4-triazol-3-amina. MX2022002881A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962905494P 2019-09-25 2019-09-25
PL43126919 2019-09-25
PCT/IB2020/058984 WO2021059220A1 (en) 2019-09-25 2020-09-25 Process for the production of 5-(4-((2 s,5 s)-5-(4-chlorobenzyl)-2-methylmorpholino)piperidin-1-yl)-1 h-1,2,4-triazol-3-amine

Publications (1)

Publication Number Publication Date
MX2022002881A true MX2022002881A (es) 2022-06-08

Family

ID=73139065

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022002881A MX2022002881A (es) 2019-09-25 2020-09-25 Proceso para la produccion de 5-(4-((2s,5s)-5-(4-clorobencil)-2-me tilmorfolino)piperidin-1-il)-1h-1,2,4-triazol-3-amina.

Country Status (13)

Country Link
US (2) US11746107B2 (es)
EP (1) EP4041726A1 (es)
JP (1) JP2022549863A (es)
KR (1) KR20220069008A (es)
CN (1) CN114466845A (es)
AU (1) AU2020356534A1 (es)
BR (1) BR112022005420A2 (es)
CA (1) CA3155177A1 (es)
IL (1) IL291569A (es)
MX (1) MX2022002881A (es)
TW (2) TW202237594A (es)
WO (1) WO2021059220A1 (es)
ZA (1) ZA202204542B (es)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2802530B1 (fr) * 1999-12-17 2002-02-22 Sanofi Synthelabo Nouveaux derives amino substitues ramifies du 3-amino-1-phenyl-1h[1,2,4]triazole, procedes pour leur preparation et compositions pharmaceutiques les contenant
AU8112101A (en) * 2000-08-08 2002-02-18 Ortho Mcneil Pharm Inc Non-imidazole aryloxypiperidines
SG11201406890YA (en) * 2012-05-30 2014-11-27 Hoffmann La Roche Triazolo compounds as pde10 inhibitors
SG11201605757SA (en) * 2013-12-20 2016-08-30 Inst Drug Discovery Substituted amino triazoles, and methods using same
PL415073A1 (pl) 2014-12-19 2016-06-20 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
GB201513740D0 (en) * 2015-08-03 2015-09-16 Heptares Therapeutics Ltd Muscarinic agonist
PL415078A1 (pl) 2015-09-04 2017-03-13 Oncoarendi Therapeutics Spółka Z Ograniczoną Odpowiedzialnością Podstawione aminotriazole przydatne jako inhibitory kwaśnej chitynazy ssaków
CN114174280A (zh) 2019-07-15 2022-03-11 昂科艾伦迪治疗法公司 可用作壳多糖酶抑制剂的取代的氨基三唑

Also Published As

Publication number Publication date
US11746107B2 (en) 2023-09-05
KR20220069008A (ko) 2022-05-26
TWI769532B (zh) 2022-07-01
ZA202204542B (en) 2023-01-25
JP2022549863A (ja) 2022-11-29
AU2020356534A1 (en) 2022-05-19
TW202237594A (zh) 2022-10-01
US20240025889A1 (en) 2024-01-25
US20210147401A1 (en) 2021-05-20
EP4041726A1 (en) 2022-08-17
CA3155177A1 (en) 2021-04-01
CN114466845A (zh) 2022-05-10
BR112022005420A2 (pt) 2022-06-21
TW202126644A (zh) 2021-07-16
WO2021059220A1 (en) 2021-04-01
IL291569A (en) 2022-05-01

Similar Documents

Publication Publication Date Title
PE20091618A1 (es) 1,2,4-triazoles trisustituidos
MY197260A (en) Fungicidal oxadiazoles
JP2007510713A5 (es)
MX2022007105A (es) Formas solidas de sal de 1,3-dihidroxi-2-(hidroximetil)propan-2-am ina de acido 2-((4-((s)-2-(5-cloropiridin-2-il)-2-metilbenzo[d][1, 3] dioxol-4-il)piperidin-1-il)metil)-1-(((s)-oxetan-2-il) metil)-1h- benzo[d]imidazol-6-carboxilico.
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
PE20131377A1 (es) Triazina-oxadiazoles
MX2010001415A (es) Procedimiento para sintetizar compuestos utiles para tratar hepatitis c.
PE20141681A1 (es) Inhibidores de btk
ES2557478T3 (es) Compuestos de pirazol y triazol como inhibidores de KSP
PE20080545A1 (es) Isoxazolinas insecticidas
HRP20120969T1 (hr) Spoj azola
ECSP11011248A (es) Nuevas formas polimórficas de sal de clorhidrato de 3-(1-{3-[5-(1-metil-piperidin-4-ilmetoxi)-pirimidin-2-il]-bencil}-6-oxo-1,6-dihidro-piridazin-3-il)-benzonitrilo y sus procesos de preparación.
JOP20210227A1 (ar) شكل بلوري من مونوهيدرات 1-(1-أوكسو-1، 2-داي هيدروأيزوكينولين-5-يل)-5-(تراي فلوروميثيل)-n-(2-(تراي فلوروميثيل)بيريدين-4-يل)-1h-بيرازول-4-كربوكساميد
CA2413243A1 (en) Sulfonyl-pyrrolidine derivatives useful for the treatment of neurological disorders
TW200726764A (en) N-linked heterocyclic antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
WO2010043849A8 (en) Process for the preparation of rufinamide
MX362102B (es) Método para producir 4-[5-(piridin-4-il)-1h-1,2,4-triazol-3-il]pir idina-2-carbonitrilo e intermediario del mismo.
MX2022002881A (es) Proceso para la produccion de 5-(4-((2s,5s)-5-(4-clorobencil)-2-me tilmorfolino)piperidin-1-il)-1h-1,2,4-triazol-3-amina.
MX2009013808A (es) Nueva forma cristalina de 3-(difluorometil)-1-metil-n-(3',4',5'-tr ifluoro[1,1'-bifenil]-2-il)-1h-pirazol-4-carboxamida.
PE20160677A1 (es) Derivados de fenilalanina sustituidos
CL2018003107A1 (es) Procedimiento para la preparación de derivados de 1-fenilo-1,2,4-triazol sustituidos por 5-hidroxialquilo
JP2005530753A5 (es)
EA201492032A1 (ru) Способ получения соединений триазола
CA2882821C (en) Pyrazole carboxamide derivatives and uses thereof as taar modulators
EA201071299A1 (ru) 5-[5-[2-(3,5-бис(трифторметил)фенил)-2-метилпропаноилметиламино]-4-(4-фтор-2-метилфенил)]-2-пиридинил-2-алкилпролинамиды в качестве антагонистов рецептора nk1